<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Colonoscopy has an appreciable miss rate for <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The goal of advanced endoscopic imaging is to improve lesion detection </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with standard definition, high-definition (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) colonoscopes have the advantage of increased field of visualization and higher resolution; narrow band imaging (NBI) utilizes narrow band filters for enhanced visualization of surface architecture and capillary pattern </plain></SENT>
<SENT sid="3" pm="."><plain>The objective of this study was to compare the yield and miss rates of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-NBI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-WLE (white light endoscopy) for the detection of <z:mp ids='MP_0003269'>colon polyps</z:mp> using meta-analysis </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A recursive literature search of randomized controlled trials (RCTs) comparing the yield of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-NBI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-WLE for detection of <z:mp ids='MP_0003269'>colon polyps</z:mp> in patients undergoing screening/surveillance colonoscopy </plain></SENT>
<SENT sid="5" pm="."><plain>Authors were contacted for missing data </plain></SENT>
<SENT sid="6" pm="."><plain>In RCT with tandem colonoscopy (RCT-t), findings from the first-pass examinations were used in the yield analysis and from the tandem pass for the miss rate analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Data on the yield of <z:mpath ids='MPATH_491'>polyps</z:mpath> were extracted, pooled, and analyzed using RevMan 4.2.9 software </plain></SENT>
<SENT sid="8" pm="."><plain>Odds ratio (OR) and 95% confidence intervals (CIs) for the pooled data for the yield and miss rates of NBI and WLE were calculated </plain></SENT>
<SENT sid="9" pm="."><plain>A fixed effect model (FEM) was used for analyses without, and a random effect model (REM) for analyses with <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: The yield analysis revealed no significant difference between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-NBI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-WLE for the detection of <z:mpath ids='MPATH_270'>adenomas</z:mpath> (six studies; n=2,284; OR: 1.01; CI: 0.74-1.37; REM); patients with <z:mpath ids='MPATH_491'>polyps</z:mpath> (six studies; n=2,275; OR: 1.15; CI: 0.8-1.64; REM); patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> (four studies; n=2,177; OR: 1.0; CI: 0.83-1.20; FEM); detection of <z:mpath ids='MPATH_270'>adenomas</z:mpath> &lt;10â€‰mm (five studies; n=1,618; OR: 1.32; CI: 0.92-1.88; FEM); flat <z:mpath ids='MPATH_270'>adenomas</z:mpath> (five studies; n=1,675; OR: 1.26; CI: 0.62-2.57; REM); and flat <z:mpath ids='MPATH_270'>adenomas</z:mpath> per patient (five studies; n=2,200; OR: 1.63; CI: 0.71-3.74; REM) </plain></SENT>
<SENT sid="11" pm="."><plain>The miss rate analysis revealed no difference in <z:mpath ids='MPATH_491'>polyp</z:mpath> miss rate (three studies; n=524; OR: 1.17; CI: 0.8-1.71; FEM) or <z:mpath ids='MPATH_270'>adenoma</z:mpath> miss rate (three studies; n=524; OR: 0.65; CI: 0.4-1.06; FEM) between the two techniques </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-WLE, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-NBI does not increase the yield of <z:mp ids='MP_0003269'>colon polyps</z:mp>, <z:mpath ids='MPATH_270'>adenomas</z:mpath>, or flat <z:mpath ids='MPATH_270'>adenomas</z:mpath>, nor does it decrease the miss rate of <z:mp ids='MP_0003269'>colon polyps</z:mp> or <z:mpath ids='MPATH_270'>adenomas</z:mpath> in patients undergoing screening/surveillance colonoscopy </plain></SENT>
</text></document>